Jeff Shrager
Fondateur chez CommerceNet
Profil
Jeff Shrager founded CollabRx, Inc. and CommerceNet.
Dr. Shrager is Fellow Emeritus at CommerceNet.
In the past he occupied the position of Chief Technology Officer for CollabRx, Inc. and Consulting Associate Professor at Stanford University.
Dr. Shrager received an undergraduate degree from the University of Pennsylvania.
Postes actifs de Jeff Shrager
| Sociétés | Poste | Début |
|---|---|---|
CommerceNet
 CommerceNet Internet Software/ServicesTechnology Services CommerceNet develops business forums to facilitate international business-to-business electronic trade, Its portfolio companies include Powerset, CommunityWalk and GigaLogix. The company was founded by Jay M. Tenenbaum, Michael Genesereth, and Jeff Shrager in 1994 and is headquartered in Los Altos, CA. | Fondateur | 01/01/1994 |
CN Ventures LLC
 CN Ventures LLC Investment ManagersFinance CN Ventures LLC (CN Ventures) is a venture capital subsidiary of CommerceNet founded in 2000. The firm is headquartered in Palo Alto, California. | Directeur Technique/Scientifique/R&D | 04/03/2010 |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Fondateur | 01/01/2018 |
Anciens postes connus de Jeff Shrager
| Sociétés | Poste | Fin |
|---|---|---|
CollabRx, Inc. /Old/
 CollabRx, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need advanced cancers in patients who have effectively exhausted the standard of care. For physicians, Collabrx provides sophisticated, yet intuitive decision support tools to help them rapidly and accurately determine which medical tests, therapies, and clinical trials should be considered in order to deliver the best possible care to their patients. For patients, CollabRx provides actionable and highly-credible information that can be shared with their oncologist in a form that supports collaborative decision making in determining a cancer treatment plan that is customized for them. For researchers, CollabRx provides a framework to categorize the molecular subtypes of cancer based on the genetic profile of the tumor, and more importantly link specific subtypes to relevant treatments and ultimately patient clinical outcomes to drive the science and medicine forward. | Directeur Technique/Scientifique/R&D | 27/09/2012 |
CollabRx, Inc.
 CollabRx, Inc. Data Processing ServicesTechnology Services CollabRx, Inc. is a data analytics company. It offers cloud-based systems, which provides clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision-making. Its CollabRx Therapy Finders product provides information to physicians and patients for rapidly determining which medical tests, therapies, and clinical trials may be considered in cancer treatment planning with a specific emphasis on the tumor genetic profile. The company was founded by Jeff Shrager in December 1989 and is headquartered in San Francisco, CA. | Fondateur | - |
| Stanford University | Corporate Officer/Principal | - |
Afferent Systems, Inc.
 Afferent Systems, Inc. Packaged SoftwareTechnology Services Part of Dassault Systèmes SA, Afferent Systems, Inc. develops software for the healthcare industry. The company is based in San Francisco, CA. Afferent Systems was acquired by MDL Information Systems, Inc., part of Dassault Systèmes SA from October 02, 2007 on July 19, 2001. | Corporate Officer/Principal | - |
Formation de Jeff Shrager
| University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Afferent Systems, Inc.
Afferent Systems, Inc. Packaged SoftwareTechnology Services Part of Dassault Systèmes SA, Afferent Systems, Inc. develops software for the healthcare industry. The company is based in San Francisco, CA. Afferent Systems was acquired by MDL Information Systems, Inc., part of Dassault Systèmes SA from October 02, 2007 on July 19, 2001. | Technology Services |
CommerceNet
CommerceNet Internet Software/ServicesTechnology Services CommerceNet develops business forums to facilitate international business-to-business electronic trade, Its portfolio companies include Powerset, CommunityWalk and GigaLogix. The company was founded by Jay M. Tenenbaum, Michael Genesereth, and Jeff Shrager in 1994 and is headquartered in Los Altos, CA. | Technology Services |
CollabRx, Inc. /Old/
CollabRx, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need advanced cancers in patients who have effectively exhausted the standard of care. For physicians, Collabrx provides sophisticated, yet intuitive decision support tools to help them rapidly and accurately determine which medical tests, therapies, and clinical trials should be considered in order to deliver the best possible care to their patients. For patients, CollabRx provides actionable and highly-credible information that can be shared with their oncologist in a form that supports collaborative decision making in determining a cancer treatment plan that is customized for them. For researchers, CollabRx provides a framework to categorize the molecular subtypes of cancer based on the genetic profile of the tumor, and more importantly link specific subtypes to relevant treatments and ultimately patient clinical outcomes to drive the science and medicine forward. | Commercial Services |
CN Ventures LLC
CN Ventures LLC Investment ManagersFinance CN Ventures LLC (CN Ventures) is a venture capital subsidiary of CommerceNet founded in 2000. The firm is headquartered in Palo Alto, California. | Finance |
CollabRx, Inc.
CollabRx, Inc. Data Processing ServicesTechnology Services CollabRx, Inc. is a data analytics company. It offers cloud-based systems, which provides clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision-making. Its CollabRx Therapy Finders product provides information to physicians and patients for rapidly determining which medical tests, therapies, and clinical trials may be considered in cancer treatment planning with a specific emphasis on the tumor genetic profile. The company was founded by Jeff Shrager in December 1989 and is headquartered in San Francisco, CA. | Technology Services |
xCures, Inc.
xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Technology Services |